In the next few years, some of the most widely-used HIV drugs will come off patent in the UK. This article asks: what are the implications for the tablets we take – and for our health? From next year in the UK, your anti-HIV drugs may start to look different. One pill may be replaced by two or three, and their appearance may change, even from one prescription to another. Names you are familiar with – Atripla, Viramune, Sustiva – may start to disappear. You will still be getting the same drugs, but in a different guise.
What you’ll be getting are generics: different versions, but essentially the same things, without a brand name attached and much cheaper for the NHS to buy.
The full article can be found here.